Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by stockbuphoonon Jul 08, 2021 9:52am
51 Views
Post# 33511369

$3.56. Wasn’t this at $7 on June 4th?

$3.56. Wasn’t this at $7 on June 4th?

Split in half since FDA approval short peak because they sold off the golden goose.

Spent $500M over 4 years to get FDA approval and then they sell Ryplazim and PPPS? 

What will they do with $75M from voucher? Not much. Pritchard should never, ever get hired again. Mind you, he's taken enough to retire here. Never risked a cent of his own money as he would not bet on a company he is leading! 

<< Previous
Bullboard Posts
Next >>